Drygin Denis 4
4 · Regulus Therapeutics Inc. · Filed Mar 1, 2022
Insider Transaction Report
Form 4
Drygin Denis
Chief Scientific Officer
Transactions
- Purchase
Common Stock
2022-03-01$0.23/sh+76,686$17,638→ 100,000 total
4 · Regulus Therapeutics Inc. · Filed Mar 1, 2022
Common Stock